Edward J. Sitar - 14 Sep 2021 Form 4 Insider Report for 9 METERS BIOPHARMA, INC.

Role: Chief Financial Officer
Signature: /s/ Edward J. Sitar
Issuer symbol: N/A
Transactions as of: 14 Sep 2021
Net transactions value: +$18,300
Form type: 4
Filing time: 15 Sep 2021, 08:12:38 UTC
Previous filing: 06 Jul 2021
Next filing: 24 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NMTR	Common stock	Purchase	$18,300	+15,000	+8.4%	$1.22^*	194,338	14 Sep 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.215 to $1.22, inclusive. The reporting person undertakes to provide to 9 Meters Biopharma, Inc., any security holder of 9 Meters Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

Content

The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.215 to $1.22, inclusive. The reporting person undertakes to provide to 9 Meters Biopharma, Inc., any security holder of 9 Meters Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.